BB Pureos Bioventures

General contacts

Investor type

VC / CVC

Founded

2017

AUM

$205 M

Location

Freienbach, Schwyz, Switzerland

Investment Ticket

$1-5 m

Investment Stage

Series B Series A Seed Late Stage (Series C+)

Region of investment

North America Europe

Investor profile last updated: 16 August, 2026

Profile

BB Pureos Bioventures is a venture capital firm based in Switzerland, specializing in investments in innovative drug development companies. Their team consists of career venture capitalists, biotech founders, former pharma and biotech executives, research scientists, medical doctors, and experienced drug developers. The firm is characterized by its passion for biotech start-ups, with a focus on the advancement of new and better medicines to address severe diseases. Founding partners include Dr. Dominik Escher and Dr. Klaus Breiner, both of whom have extensive experience in the biotech investment landscape.

The firm primarily invests in companies focused on developing the next generation of biological drugs and treatments for severe conditions. BB Pureos Bioventures typically engages in funding rounds from Series A through Late Stage, with investments likely ranging from $1 million to $5 million, inferred from typical venture capital practices. Their investment focus is global, with significant activities across North America and Europe.

Notable investments include Acrivon Therapeutics, which develops cancer drugs with companion diagnostics, and Araris Biotech, known for its work on antibody-drug conjugates. Other portfolio companies include Alentis Therapeutics, AnaCardio, and Callio Therapeutics, each contributing to diverse advances in cancer and fibrotic disease therapies.

Industry

Pharmaceuticals Medical Devices Healthcare Services Biotechnology HealthTech Life Sciences

BB Pureos Bioventures Funds

Name	Type	Industry	Stage	Region	Size	AUM	Launch date
BB Pureos Bioventures LP	Venture Capital (VC)	Biotechnology Healthcare Services Medical Devices Pharmaceuticals Life Sciences	Pre-seed Seed	North America Europe Asia	$5-10 m	$205 M	April 2021

Contacts

Name

Title

Social Networks

Martin Münchbach Managing Partner

Managing Partner

m•••@•••

Klaus Breiner Managing Partner

Managing Partner

k•••@•••

Upgrade to see contacts

pEgKkPYWhDvGT65n pEgKkPYWhDvGT65n

pEgKkPYWhDvGT65n

[email protected]

pEgKkPYWhDvGT65n pEgKkPYWhDvGT65n

pEgKkPYWhDvGT65n

[email protected]

pEgKkPYWhDvGT65n pEgKkPYWhDvGT65n

pEgKkPYWhDvGT65n

[email protected]

Investment-team contacts for BB Pureos Bioventures — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.

Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about BB Pureos Bioventures

Is BB Pureos Bioventures a venture capital or private equity firm?

BB Pureos Bioventures is a venture capital firm that also operates as a corporate VC (CVC). It backs companies at Series B, Series A, Seed and Late Stage (Series C+), writing tickets of $1-5 m.

Where is BB Pureos Bioventures located?

BB Pureos Bioventures is located in Freienbach, Schwyz, Switzerland.

When was BB Pureos Bioventures founded?

BB Pureos Bioventures was founded in 2017.

What sectors and industries does BB Pureos Bioventures invest in?

BB Pureos Bioventures invests in companies and startups in Pharmaceuticals, Medical Devices, Healthcare Services, Biotechnology, HealthTech, Life Sciences.

What is BB Pureos Bioventures geographical focus of investments?

BB Pureos Bioventures invests in companies and startups in North America, Europe.

At what stages of companies and startups does BB Pureos Bioventures typically invest in?

BB Pureos Bioventures invests in companies and startups at Series B, Series A, Seed, Late Stage (Series C+).

What is the usual amount of BB Pureos Bioventures investment?

BB Pureos Bioventures usually invests $1-5 m on average.

What is the amount of assets of under management (AUM) for BB Pureos Bioventures?

BB Pureos Bioventures has around $205m assets under management.

When was BB Pureos Bioventures last fund created?

BB Pureos Bioventures last fund was created/launched in 2021-04-22

What are the contacts of BB Pureos Bioventures?

BB Pureos Bioventures can be reached through its website pureosbio.com and its LinkedIn page. Its general enquiries address is [email protected]. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for BB Pureos Bioventures — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

Can I access BB Pureos Bioventures data via API or MCP?

Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query BB Pureos Bioventures directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.

When was the BB Pureos Bioventures profile last updated?

Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 16 August, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.